The Joint Institute for Translational and Clinical Research is a unique partnership between the UMHS and PUHSC. It sponsors high-impact collaborative research that leverages the unique strengths of each institution to advance global health. The JI research programs currently focus on four pervasive medical conditions: cardiovascular disease, liver disease, pulmonary disease, and renal disease. In each of these areas, panels of experts from both universities are conducting clinical and translational research studies. Three infrastructure 'cores' support both the administrative and research aspects of the JI: Biorepository and Biomedical Informatics Core, Collaboration Core, and the IRB and Human Protection Core. Through this partnership, UMHS and PUHSC hope to enable scientists to translate basic research more quickly and efficiently into medical practice and improve outcomes for patients in the US, in China, and around the world.
Kolars JC, Fang W, Zheng K, Huang AY, Sun Q, Wang Y, Woolliscroft JO, Ke Y.Collaboration Platforms in China for Translational and Clinical Research: The Partnership Between Peking University Health Science Center and the University of Michigan Medical School. Acad Med. 2016 Apr 26. [Epub ahead of print] PubMed PMID: 27119322.
View the abstract and link to the full publication here.